Erbitus prolongs life expectancy for lung cancer patients: study (AFP)AFP - The cancer drug Erbitux (cetuximab) prolonged the lives of patients with advanced lung cancer by five weeks, according to a clinical study described Sunday as an important gain for such individuals.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/afp/ushealthcancer_080602064818.html